Prosecution Insights
Last updated: April 19, 2026

Sanofi Biotechnology

4 pending office actions

Portfolio Summary

4
Total Pending OAs
2
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18452155 METHODS FOR PREVENTING OR TREATING ALLERGY BY ADMINISTERING AN IL-4R ANTAGONIST SZPERKA, MICHAEL EDWARD 1641 Final Rejection Aug 18, 2023
17926123 COMPOSITIONS AND METHODS FOR TREATING NONINFLAMMATORY PAIN IN SUBJECTS WITH RHEUMATOID ARTHRITIS OUSPENSKI, ILIA I 1644 Non-Final OA Jun 15, 2023
17482273 METHODS FOR TREATING SEVERE ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R INHIBITOR LIEB, JEANETTE M 1654 Final Rejection Sep 22, 2021
17327504 METHODS FOR TREATING EOSINOPHILIC ESOPHAGITIS BY ADMINISTERING AN IL-4R INHIBITOR DEBERRY, REGINA M 1647 Non-Final OA May 21, 2021

Managing Sanofi Biotechnology's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month